Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2024-05-13 00:00:00 ET · period of report 2024-05-10 · accession 0001055726-24-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-13 | 2024-05-10 | INO | Shea Jacqueline Elizabeth | CEO, Dir | F - Tax | $10.65 | -2,392 | 23.6K | -9% | -$25.5K |
| D | 2024-05-13 | 2024-05-10 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | — | +5,500 | 26.0K | +27% | — |
| D | 2024-05-13 | 2024-05-10 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | $0.00 | -5,500 | 5,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | F | D | 2,392 | $10.65 | 23,620 | D | — | — | (F3) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 2 | Common | Common Stock | 2024-05-10 | M | A | 5,500 | — | 26,012 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. |
| 3 | Derivative | Restricted Stock Unit | 2024-05-10 | M | D | 5,500 | $0.00 | 5,500 | D | — · — to — | 5,500 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |